Cargando…
Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation
Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk of in-stent thrombosis, acute myocardial infarction an...
Autores principales: | Chin, Nicholas, Rangamuwa, Kanishka, Mariasoosai, Raymond, Carnes, Jonathan, Thien, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313754/ https://www.ncbi.nlm.nih.gov/pubmed/25653921 http://dx.doi.org/10.5415/apallergy.2015.5.1.51 |
Ejemplares similares
-
Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
por: Anantharajah, Anthea, et al.
Publicado: (2019) -
Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
por: Usai, Paolo, et al.
Publicado: (2019) -
An epidemic of thunderstorm asthma in Melbourne 2016: asthma, rhinitis, and other previous allergies
por: Rangamuwa, Kanishka B., et al.
Publicado: (2017) -
Clinical study to monitor dentinal hypersensitivity with episodic use of a
desensitising dentifrice
por: Mason, Stephen, et al.
Publicado: (2017) -
Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin
por: Matheu, Victor, et al.
Publicado: (2005)